Greytown Advisors Inc. Simulations Plus, Inc. Transaction History

Greytown Advisors Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$40.55 - $51.76 $851 - $1,086	21 Added 0.52%	4,084 $201,000
Q1 2022 May 16, 2022	SELL	$36.56 - $50.98 $51,330 - $71,575	-1,404 Reduced 25.68%	4,063 $207,000
Q4 2021 Feb 14, 2022	SELL	$37.1 - $57.45 $2,559 - $3,964	-69 Reduced 1.25%	5,467 $259,000
Q3 2021 Nov 15, 2021	BUY	$38.45 - $55.66 $19,994 - $28,943	520 Added 10.37%	5,536 $219,000
Q2 2021 Aug 16, 2021	BUY	$49.67 - $68.96 $37,500 - $52,064	755 Added 17.72%	5,016 $275,000

Q1 2021 May 17, 2021	BUY	$60.06 - $89.52 $35,135 - $52,369	585 Added 15.91%	4,261 $269,000
Q4 2020 Feb 16, 2021	BUY	$53.26 - $77.18 $7,509 - $10,882	141 Added 3.99%	3,676 $264,000
Q2 2020 Aug 14, 2020	BUY	$32.91 - $59.82 $116,336 - $211,463	3,535 New	3,535 $211,000

181

17.3M

38.3K

27.7K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $351M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Greytown Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Greytown Advisors Inc. with notifications on news.